CASP6 and glioma: To further confirm the predictive value of CASP6 expression as a new prognostic biomarker for glioma, we conducted a meta-analysis, which showed that based on its HR and 95% CI (2.18 and 1.24–3.82, respectively), CASP6 expression is a robust prognostic indicator.